Skip to content
Cabaletta Bio logo

Cabaletta Bio Alternatives & Competitors

12 companies similar to Cabaletta Bio — Engineered T cell therapies designed for the treatment of patients with autoimmu...

Companies similar to Cabaletta Bio

Barinthus Biotherapeutics logo — alternative to Cabaletta Bio

Barinthus Biotherapeutics

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunother...

Immunocore logo — alternative to Cabaletta Bio

Immunocore

Science to Transform Lives

Imcyse SA logo — alternative to Cabaletta Bio

Imcyse SA

Pioneering the development of Imotopes™ to prevent, stop and potentially cure autoimmune d...

Biodexa Pharmaceuticals PLC logo — alternative to Cabaletta Bio

Biodexa Pharmaceuticals PLC

Advancing Medicines for a Brighter Future

Rival Readout

Competing with Cabaletta Bio? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Autolus Therapeutics logo — alternative to Cabaletta Bio

Autolus Therapeutics

Focused on the development of precisely targeted, controlled & highly active T cell therap...

Upstream Bio logo — alternative to Cabaletta Bio

Upstream Bio

Developing treatments for inflammatory diseases

Entelexo Biotherapeutics logo — alternative to Cabaletta Bio

Entelexo Biotherapeutics

Entelexo has created a novel platform technology for engineering exosomes as a new approac...

Aspen Neuroscience, Inc. logo — alternative to Cabaletta Bio

Aspen Neuroscience, Inc.

Developing autologous iPSC-derived cell replacement therapies for Parkinson’s disease and...

Glyscend Therapeutics logo — alternative to Cabaletta Bio

Glyscend Therapeutics

Advancing a new class of oral gut-targeted polymeric drugs for the treatment of T2D and Ob...

Avidity Biosciences, Inc. logo — alternative to Cabaletta Bio

Avidity Biosciences, Inc.

At Avidity, we are developing a new class of oligonucleotide-based therapies.

Heartseed Inc. logo — alternative to Cabaletta Bio

Heartseed Inc.

Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiom...

Dyne Therapeutics logo — alternative to Cabaletta Bio

Dyne Therapeutics

Advancing life-transforming therapies for serious muscle diseases

About Cabaletta Bio

Cabaletta Bio (Nasdaq: CABA) is at the forefront of innovation within the biotechnology sector, focusing on engineered T cell therapies aimed at treating autoimmune diseases. Founded in 2017 and headquartered in Philadelphia, PA, this clinical-stage company is pioneering potentially curative medical treatments, attract...

Services

Development of T cell therapies for autoimmune diseases, Conducting Phase 1/2 clinical trials, CD19 chimeric antigen receptor T cell therapy development, Research and development of CABA® platform

Target Customers

Patients with autoimmune diseases, Healthcare providers specializing in rheumatology, dermatology, and neurology, Biotechnology researchers and collaborators, Investors in biopharmaceuticals

Business keywords

Engineered T Cell Therapies, Autoimmune Diseases, Clinical-stage, CARTA Strategy, CAART Strategy, B Cell-mediated Autoimmune Diseases, CD19-CAR T, Mucosal Pemphigus Vulgaris, MuSK Myasthenia Gravis, Chimeric Antigen Receptor, Autologous CAAR T Cells, Therapeutic Platform, Selective Targeting, Partnership With Penn

Business Model

B2B, B2D

Revenue Model

Product Sales, Licensing, Service Fee

Frequently Asked Questions

Companies similar to Cabaletta Bio include Barinthus Biotherapeutics, Immunocore, Imcyse SA, Biodexa Pharmaceuticals PLC, Autolus Therapeutics. They work in Biotechnology and Pharmaceutical and share Cabaletta Bio's focus on autoimmune diseases.
Bounce Watch lists 12 companies that share Cabaletta Bio's industries and are closest to it in business tags, services, target customers, business model and size.
Cabaletta Bio (Nasdaq: CABA) is at the forefront of innovation within the biotechnology sector, focusing on engineered T cell therapies aimed at treating autoimmune diseases. Founded in 2017 and headquartered in Philadelphia, PA, this clinical-stage company is pioneering potentially curative medical treatments, attract...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Cabaletta Bio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Cabaletta Bio on 9 Jun 2026. The 12 companies listed here were last checked between 23 Feb 2026 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout